Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
Both organisations enter into a long- term collaboration to expand patient access in India
Both organisations enter into a long- term collaboration to expand patient access in India
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Subscribe To Our Newsletter & Stay Updated